<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Everest Medicines Announces China NMPA Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis	</title>
	<atom:link href="https://9krapalm.com/everest-medicines-announces-china-nmpa-approval-of-velsipity-for-adults-with-moderately-to-severely-active-ulcerative-colitis/feed/" rel="self" type="application/rss+xml" />
	<link>https://9krapalm.com/everest-medicines-announces-china-nmpa-approval-of-velsipity-for-adults-with-moderately-to-severely-active-ulcerative-colitis/</link>
	<description>เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm</description>
	<lastBuildDate>Fri, 06 Feb 2026 05:46:57 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.1</generator>
</channel>
</rss>
